These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 23408680)
41. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Unemo M; Golparian D; Hestner A Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645 [TBL] [Abstract][Full Text] [Related]
42. Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins. Regnath T; Mertes T; Ignatius R Euro Surveill; 2016 Sep; 21(36):. PubMed ID: 27632642 [TBL] [Abstract][Full Text] [Related]
43. Comparison of enoxacin and ceftriaxone in the treatment of uncomplicated gonorrhea. Covino JM; Smith BL; Cummings MC; Benes S; Draft K; McCormack WM Sex Transm Dis; 1993; 20(4):227-9. PubMed ID: 8211540 [TBL] [Abstract][Full Text] [Related]
48. Should urologists care for the pharyngeal infection of Neisseria gonorrhoeae or Chlamydia trachomatis when we treat male urethritis? Hamasuna R; Takahashi S; Uehara S; Matsumoto T J Infect Chemother; 2012 Jun; 18(3):410-3. PubMed ID: 22302695 [TBL] [Abstract][Full Text] [Related]
49. Multidrug-resistant Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905 [TBL] [Abstract][Full Text] [Related]
51. Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010. Kirkcaldy RD; Zaidi A; Hook EW; Holmes KK; Soge O; del Rio C; Hall G; Papp J; Bolan G; Weinstock HS Ann Intern Med; 2013 Mar; 158(5 Pt 1):321-8. PubMed ID: 23460055 [TBL] [Abstract][Full Text] [Related]
52. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015. Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M; BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203 [TBL] [Abstract][Full Text] [Related]
53. Management of Gonorrhea in Adolescents and Adults in the United States. Kidd S; Workowski KA Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S785-801. PubMed ID: 26602618 [TBL] [Abstract][Full Text] [Related]
54. An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England. Chisholm SA; Wilson J; Alexander S; Tripodo F; Al-Shahib A; Schaefer U; Lythgow K; Fifer H Sex Transm Infect; 2016 Aug; 92(5):365-7. PubMed ID: 26601852 [TBL] [Abstract][Full Text] [Related]
55. Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: a worldwide summary. Echols RM; Heyd A; O'Keeffe BJ; Schacht P Sex Transm Dis; 1994; 21(6):345-52. PubMed ID: 7871449 [TBL] [Abstract][Full Text] [Related]
56. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group. Handsfield HH; McCormack WM; Hook EW; Douglas JM; Covino JM; Verdon MS; Reichart CA; Ehret JM N Engl J Med; 1991 Nov; 325(19):1337-41. PubMed ID: 1922235 [TBL] [Abstract][Full Text] [Related]
57. Treatment of pharyngeal gonorrhea due to beta-lactamase-producing gonococci. Lindberg M; Ringertz O; Sandström E Br J Vener Dis; 1982 Apr; 58(2):101-4. PubMed ID: 6461385 [TBL] [Abstract][Full Text] [Related]
58. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018. Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707 [TBL] [Abstract][Full Text] [Related]
59. Potential deleterious effects of promoting the use of ceftriaxone in the treatment of Neisseria gonorrhoeae. Golden MR; Barbee LA; Kerani R; Dombrowski JC Sex Transm Dis; 2014 Oct; 41(10):619-25. PubMed ID: 25211259 [TBL] [Abstract][Full Text] [Related]
60. A Phase 1 Pharmacokinetic and Safety Study of Extended-Duration, High-dose Cefixime for Cephalosporin-resistant Neisseria gonorrhoeae in the Pharynx. Barbee LA; Nayak SU; Blumer JL; OʼRiordan MA; Gray W; Zenilman JM; Golden MR; Griffiss JM Sex Transm Dis; 2018 Oct; 45(10):677-683. PubMed ID: 29624558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]